🇺🇸 FDA
Patent

US 11274342

Systems and methods for sequencing T cell receptors and uses thereof

granted A61KA61K2039/505A61K2239/50

Quick answer

US patent 11274342 (Systems and methods for sequencing T cell receptors and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K2239/50, A61K40/11, A61K40/32